Letter: Oral or Intravenous Lidocaine Administration to Perform MEGX Test?

[1] Muñoz AE(1999)Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration Dig Dis Sci 44 789-795

[2] Miguez C(1995)Quantitative tests of liver function Aliment Pharmacol Ther 9 263-270

[3] Rubio M(1987)Monoethylglycinexylidide formation kinetics: A novel approach to assessment of liver function J Clin Chem Clin Biochem 25 845-853

[4] Bartellini M(1992)Drug metabolism by cytochromes P450 in the liver and small bowel Gastorenterol Clin North Am 21 511-526

[5] Levi D(1991)Predictors of one-year pretransplant survival in patients with cirrhosis Hepatology 14 1029-1034

[6] Podestà A(1994)Monoethylglycinexylidide test: A prognostic indicator of survival in cirrhosis Hepatology 20 383-387

[7] Niselman V(1994)Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis Hepatology 19 933-940

[8] Terg R(1993)Formation kinetics of the lidocaine metabolite (MEGX) in patients with chronic active hepatitis and cirrhosis Eur J Gastroenterol Hepatol 5 845-851

[9] Jalan R(1997)Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease Am J Gastroenterol 92 2268-2273

[10] Hayes PC(1998)Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis Hepato-Gastroenterol 45 154-159

[1] Muñoz AE(1999)Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration Dig Dis Sci 44 789-795

[2] Miguez C(1995)Quantitative tests of liver function Aliment Pharmacol Ther 9 263-270

[3] Rubio M(1987)Monoethylglycinexylidide formation kinetics: A novel approach to assessment of liver function J Clin Chem Clin Biochem 25 845-853

[4] Bartellini M(1992)Drug metabolism by cytochromes P450 in the liver and small bowel Gastorenterol Clin North Am 21 511-526

[5] Levi D(1991)Predictors of one-year pretransplant survival in patients with cirrhosis Hepatology 14 1029-1034

[6] Podestà A(1994)Monoethylglycinexylidide test: A prognostic indicator of survival in cirrhosis Hepatology 20 383-387

[7] Niselman V(1994)Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis Hepatology 19 933-940

[8] Terg R(1993)Formation kinetics of the lidocaine metabolite (MEGX) in patients with chronic active hepatitis and cirrhosis Eur J Gastroenterol Hepatol 5 845-851

[9] Jalan R(1997)Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease Am J Gastroenterol 92 2268-2273

[10] Hayes PC(1998)Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis Hepato-Gastroenterol 45 154-159